In the vitro, amuvatinib inhibited the growth of NRAS‐mutant melanoma cell by inducing G2/M‐phase cell cycle arrest and apoptosis, but not BRAF‐mutant melanoma cell lines [351]. Here, NRAS is linked to melanoma.